Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.

Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.

  • @ghostBonesEnglish
    3•1 year ago

    I have often said that the most intolerable offense in America is obstruction of profit, based on the sheer volume of litigation that fits that description.